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From the Greek pseudo (“false”) + monas (“unit”). In 1894, German botanist Walter Migula coined the term 
Pseudomonas for a genus he described as, “Cells with polar organs of motility. Formation of spores occurs in some 
species, but it is rare.” Migula never clarifi ed the etymology of the term. However, the description of Pseudomonas 
as “false unit” does not make much sense, and an alternative explanation posits that Migula “had not traced directly 
the Greek ancestry of the name, but had simply created the name Pseudomonas for the resemblance of the cells 
to those of the nanofl agellate Monas in both size and active motility.” Monas was coined by Danish naturist Otto 
Friedrich Müller in 1773 to describe a genus of “infusoria” characterized as “vermis inconspicuous, simplicissimus, 
pellucidus, punctiformis” (“inconspicuous worm, simple, transparent, tiny”).
Pseudomonas aeruginosa [adj. fem. of aerūginōsus] from Latin aerūgō (“copper rust or verdigris,” hence 
green) + -ōsus (added to a noun to form an adjective indicating an abundance of that noun) is named for the green-
ish-blue color of bacterial colonies. The organism has emerged as one of the most serious causes of nosocomial 
infections.
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